Literature DB >> 17166790

Movement disorders: advances on many fronts.

Eduardo Tolosa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17166790     DOI： 10.1016/S1474-4422(06)70661-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.

Authors:  J Alegre-Abarrategui; O Ansorge; M Esiri; R Wade-Martins
Journal:  Neuropathol Appl Neurobiol       Date:  2007-10-26       Impact factor: 8.090

3.  Older onset essential tremor: More rapid progression and more degenerative pathology.

Authors:  Elan D Louis; Phyllis L Faust; Jean-Paul G Vonsattel; Lawrence S Honig; Claire Henchcliffe; Rajesh Pahwa; Kelly E Lyons; Eileen Rios; Cordelia Erickson-Davis; Carol B Moskowitz; Arlene Lawton
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

Review 4.  Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Authors:  Sumit Sarkar; James Raymick; Syed Imam
Journal:  Int J Mol Sci       Date:  2016-06-08       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.